...
首页> 外文期刊>Journal of Medicinal Chemistry >Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among US FDA Approved Pharmaceuticals
【24h】

Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among US FDA Approved Pharmaceuticals

机译:美国FDA批准的药物中氮杂环的结构多样性,取代模式和频率的分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Nitrogen heterocycles are among the most significant structural components of pharmaceuticals. Analysis of our database of U.S. FDA approved drugs reveals that 59% of unique small-molecule drugs contain a nitrogen heterocycle. In this review we report on the top 25 most commonly utilized nitrogen heterocycles found in pharmaceuticals. The main part of our analysis is divided into seven sections: (1) three- and four-membered heterocycles, (2) five-, (3) six-, and (4) seven- and eight-membered heterocycles, as well as (5) fused, (6) bridged bicyclic, and (7) macrocyclic nitrogen heterocycles. Each section reveals the top nitrogen heterocyclic structures and their relative impact for that ring type. For the most commonly used nitrogen heterocycles, we report detailed substitution patterns, highlight common architectural cores, and discuss unusual or rare structures.
机译:氮杂环是药物中最重要的结构成分之一。对我们获得美国FDA批准的药物的数据库的分析表明,有59%的独特小分子药物含有氮杂环。在这篇综述中,我们报告了在药物中发现的前25个最常用的氮杂环。我们的分析主要分为七个部分:(1)三元和四元杂环,(2)五元,(3)六元和(4)七元和八元杂环,以及(5)稠合,(6)桥联双环和(7)大环氮杂环。每个部分都揭示了顶部氮杂环结构及其对该环类型的相对影响。对于最常用的氮杂环,我们报告了详细的取代模式,突出了常见的建筑核心并讨论了异常或稀有结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号